SEC 13F Intelligence

Ghost Tree Capital, LLC / TARS

Ghost Tree Capital, LLC’s Tarsus Pharmaceuticals Inc Position

Does Ghost Tree Capital, LLC own Tarsus Pharmaceuticals Inc (TARS)? Yes — 350.0K shares worth $12M (+3.48% of its 13F portfolio) as of Q3 2024, up from 235.0K shares the prior filed quarter.

Position Value
$12M
Q3 2024
Shares
350.0K
% of Portfolio
+3.48%
Quarters Held
14
currently held

Position History TARS

Reported value by quarter
Q2 ’21: $5MQ2 ’21Q3 ’21: $4MQ4 ’21: $4MQ4 ’21Q1 ’22: $2MQ2 ’22: $2MQ2 ’22Q3 ’22: $2MQ4 ’22: $1MQ4 ’22Q1 ’23: $1MQ2 ’23: $3MQ2 ’23Q3 ’23: $7MQ4 ’23: $6MQ4 ’23Q1 ’24: $11MQ2 ’24: $6MQ2 ’24Q3 ’24: $12Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 2024350.0K$12M+3.48%
Q2 2024235.0K$6M+2.00%
Q1 2024300.0K$11M+3.02%
Q4 2023300.0K$6M+1.99%
Q3 2023400.0K$7M+2.34%
Q2 2023150.0K$3M+0.89%
Q1 202380.0K$1M+0.30%
Q4 202280.0K$1M+0.50%
Q3 2022120.0K$2M+0.58%
Q2 2022120.0K$2M+0.91%
Q1 2022120.0K$2M+0.44%
Q4 2021170.0K$4M+1.37%
Q3 2021170.0K$4M+1.07%
Q2 2021170.0K$5M+1.35%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ghost Tree Capital, LLC’s full portfolio or all institutional holders of TARS.